Back to companies
PharmaCyte Biotech, Inc.
PMCBUSNASDAQPharmaceuticals & HealthcarePharmaCyte Biotech, Inc.
Revenue
—
FY2026
Operating income
-$6.9mn
FY2026
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API